Cypress Wealth Services’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Hold |
20,000
| – | – | 0.03% | 307 |
|
|
2025
Q1 | $150K | Hold |
20,000
| – | – | 0.03% | 276 |
|
|
2024
Q4 | $150K | Hold |
20,000
| – | – | 0.03% | 272 |
|
|
2024
Q3 | $152K | Hold |
20,000
| – | – | 0.03% | 275 |
|
|
2024
Q2 | $124K | Hold |
20,000
| – | – | 0.03% | 253 |
|
|
2024
Q1 | $102K | Hold |
20,000
| – | – | 0.02% | 257 |
|
|
2023
Q4 | $120K | Hold |
20,000
| – | – | 0.03% | 240 |
|
|
2023
Q3 | $142K | Hold |
20,000
| – | – | 0.04% | 231 |
|
|
2023
Q2 | $144K | Hold |
20,000
| – | – | 0.04% | 242 |
|
|
2023
Q1 | $167K | Hold |
20,000
| – | – | 0.05% | 237 |
|
|
2022
Q4 | $230K | Hold |
20,000
| – | – | 0.07% | 209 |
|
|
2022
Q3 | $273K | Hold |
20,000
| – | – | 0.09% | 179 |
|
|
2022
Q2 | $212K | Hold |
20,000
| – | – | 0.07% | 209 |
|
|
2022
Q1 | $325K | Hold |
20,000
| – | – | 0.09% | 167 |
|
|
2021
Q4 | $277K | Hold |
20,000
| – | – | 0.08% | 182 |
|
|
2021
Q3 | $287K | Hold |
20,000
| – | – | 0.09% | 176 |
|
|
2021
Q2 | $316K | Hold |
20,000
| – | – | 0.09% | 191 |
|
|
2021
Q1 | $203K | Hold |
20,000
| – | – | 0.04% | 280 |
|
|
2020
Q4 | $149K | Buy |
+20,000
| New | +$149K | 0.03% | 280 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$48K | – | 20 |
|
|
2020
Q2 | $48K | Hold |
10,000
| – | – | 0.01% | 272 |
|
|
2020
Q1 | $20K | Buy |
+10,000
| New | +$20K | 0.01% | 246 |
|